These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 30595556)

  • 21. Defining and predicting early recurrence in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
    Zheng Z; Wang X; Huang Y; Lu X; Huang Z; Chi P
    Eur J Surg Oncol; 2020 Nov; 46(11):2057-2063. PubMed ID: 32782202
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prognostic factors for local recurrence in patients with rectal cancer submitted to neoadjuvant chemoradiotherapy and total mesorectal excision.
    Nahas CSR; Nahas SC; Marques CFS; Ribeiro Junior U; Bustamante-Lopez L; Cotti GC; Imperiale AR; Pinto RA; Cecconello I
    Clinics (Sao Paulo); 2024; 79():100464. PubMed ID: 39126876
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Value of postoperative adjuvant chemotherapy in locally advanced rectal cancer patients with ypT1-4N0 after neo-adjuvant chemoradiotherapy].
    You KY; Peng HH; Gao YH; Chen L; Zhou GQ; Chang H; Du XJ; Xiao L; Zeng ZF; Wen BX; Liu MZ
    Zhonghua Zhong Liu Za Zhi; 2013 Sep; 35(9):708-13. PubMed ID: 24332061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term Oncologic Outcomes After Neoadjuvant Chemoradiation Followed by Intersphincteric Resection With Coloanal Anastomosis for Locally Advanced Low Rectal Cancer.
    Park JS; Park SY; Kim HJ; Cho SH; Kwak SG; Choi GS
    Dis Colon Rectum; 2019 Apr; 62(4):408-416. PubMed ID: 30688680
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision.
    Kim CH; Lee SY; Kim HR; Kim YJ
    Medicine (Baltimore); 2015 Aug; 94(31):e1291. PubMed ID: 26252304
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Can serum dynamics of carcinoembryonic antigen level during neoadjuvant chemoradiotherapy in rectal cancer predict tumor response and recurrence? A multi-institutional retrospective study.
    Chung MJ; Nam TK; Jeong JU; Kim SH; Kim K; Jang HS; Jeong BK; Lee JH
    Int J Colorectal Dis; 2016 Sep; 31(9):1595-601. PubMed ID: 27464635
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial.
    Garcia-Aguilar J; Renfro LA; Chow OS; Shi Q; Carrero XW; Lynn PB; Thomas CR; Chan E; Cataldo PA; Marcet JE; Medich DS; Johnson CS; Oommen SC; Wolff BG; Pigazzi A; McNevin SM; Pons RK; Bleday R
    Lancet Oncol; 2015 Nov; 16(15):1537-1546. PubMed ID: 26474521
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of postoperative adjuvant radiotherapy on recurrence and survival in stage III rectal cancer.
    Huh JW; Lim SW; Kim HR; Kim YJ
    J Gastrointest Surg; 2011 Jun; 15(6):963-70. PubMed ID: 21479672
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis.
    Kim Y; Kim DY; Kim TH; Kim SY; Baek JY; Kim MJ; Chang HJ; Cha Y; Park SC; Oh JH
    Br J Radiol; 2018 Dec; 91(1092):20180143. PubMed ID: 30129789
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of Lymph Node Ratio on Oncologic Outcomes in ypStage III Rectal Cancer Patients Treated with Neoadjuvant Chemoradiotherapy followed by Total Mesorectal Excision, and Postoperative Adjuvant Chemotherapy.
    Koo T; Song C; Kim JS; Kim K; Chie EK; Kang SB; Lee KW; Kim JH; Jeong SY; Kim TY
    PLoS One; 2015; 10(9):e0138728. PubMed ID: 26381522
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic Role of Carcinoembryonic Antigen Level after Preoperative Chemoradiotherapy in Patients with Rectal Cancer.
    Huh JW; Yun SH; Kim SH; Park YA; Cho YB; Kim HC; Lee WY; Park HC; Choi DH; Park JO; Park YS; Chun HK
    J Gastrointest Surg; 2018 Oct; 22(10):1772-1778. PubMed ID: 29845570
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Oncologic outcomes after neoadjuvant chemoradiation followed by curative resection with tumor-specific mesorectal excision for fixed locally advanced rectal cancer: Impact of postirradiated pathologic downstaging on local recurrence and survival.
    Kim NK; Baik SH; Seong JS; Kim H; Roh JK; Lee KY; Sohn SK; Cho CH
    Ann Surg; 2006 Dec; 244(6):1024-30. PubMed ID: 17122629
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience.
    AlSaeed EF; Tunio M; Zubaidi A; Al-Obaid O; Ahmed AK; Al-Omar OA; Abid EA; Alsiwat MJ
    Ann Saudi Med; 2015; 35(1):23-30. PubMed ID: 26142934
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The impact of tumor regression grade on long-term survival in locally advanced rectal cancer treated with preoperative chemoradiotherapy.
    Sakin A; Sahin S; Sengul Samanci N; Yasar N; Demir C; Geredeli C; Erhan SS; Akboru MH; Cihan S
    J Oncol Pharm Pract; 2020 Oct; 26(7):1611-1620. PubMed ID: 32046577
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Postoperative Adjuvant Chemotherapy Following Long-course Chemoradiotherapy in Stage II Rectal Cancer.
    Loree JM; Kennecke HF; Lee-Ying RM; Goodwin RA; Powell ED; Tang PA; Price Hiller JA; Vickers MM; Cheung WY
    Am J Clin Oncol; 2018 Jul; 41(7):643-648. PubMed ID: 27819876
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reappraisal of pretreatment carcinoembryonic antigen in patients with rectal cancer receiving preoperative chemoradiotherapy.
    Yeo SG; Kim DY; Chang HJ; Park JW; Oh JH; Kim BC; Baek JY; Kim SY; Kim TH
    Tumori; 2013; 99(1):93-9. PubMed ID: 23549007
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oncologic outcomes of pathologic stage I lower rectal cancer with or without preoperative chemoradiotherapy: are they comparable?
    Huh JW; Kim CH; Kim HR; Kim YJ
    Surgery; 2011 Nov; 150(5):980-4. PubMed ID: 21875732
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparative Outcomes of Neoadjuvant Treatment Prior to Total Mesorectal Excision and Total Mesorectal Excision Alone in Selected Stage II/III Low and Mid Rectal Cancer.
    Kulu Y; Tarantino I; Billeter AT; Diener MK; Schmidt T; Büchler MW; Ulrich A
    Ann Surg Oncol; 2016 Jan; 23(1):106-13. PubMed ID: 26305025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effects of chemoradiotherapy on recurrence and survival in locally advanced rectal cancers with curative total mesorectal excision: a prospective, nonrandomized study.
    Akgun E; Ozkok S; Tekin M; Yoldas T; Caliskan C; Kose T; Karabulut B; Sezak M; Elmas N; Ozutemiz O
    World J Surg Oncol; 2017 Nov; 15(1):205. PubMed ID: 29166925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Posttreatment TNM staging is a prognostic indicator of survival and recurrence in tethered or fixed rectal carcinoma after preoperative chemotherapy and radiotherapy.
    Chan AK; Wong A; Jenken D; Heine J; Buie D; Johnson D
    Int J Radiat Oncol Biol Phys; 2005 Mar; 61(3):665-77. PubMed ID: 15708244
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.